pharmacie et médicaments – Dispensation et coût des traitements anticancéreux

This written question asks about the costs and dispensing methods for cancer treatments in France. It seeks to understand how these vital medications are made available to patients and the financial implications involved. The question affects cancer patients, healthcare providers, and pharmaceutical companies. It aims to shed light on potential disparities in access and cost, impacting treatment accessibility and affordability.